International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company
Moscow Stock ExchangeTotal Valuation
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company carries a market capitalization of 1.62B, placing it among publicly traded companies globally. Its enterprise value stands at 144.59M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.62B |
| Enterprise Value | 144.59M |
Share Statistics
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company currently has 14.93M shares outstanding.
| Shares Outstanding | 14.93M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Enterprise Valuation
On an enterprise value basis, International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company trades at an EV/EBITDA multiple of 3.51 and an EV/FCF ratio of 17.45. The EV/Sales ratio of 1.10 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.51 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.10 |
| EV / EBITDA | 3.51 |
| EV / EBIT | 3.51 |
| EV / FCF | 17.45 |
Financial Position
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company maintains a current ratio of 1.13, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 39.45, indicating elevated leverage, while an interest coverage ratio of 4.98 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.13 |
| Quick Ratio | 0.65 |
| Debt / Equity | 39.45 |
| Debt / EBITDA | 5.64 |
| Interest Coverage | 4.98 |
Financial Efficiency
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company posts a return on equity of 72.46 and a return on invested capital of 7.44.
| Return on Equity (ROE) | 72.46 |
| Return on Assets (ROA) | 5.56 |
| Return on Invested Capital (ROIC) | 7.44 |
| Return on Capital Employed (ROCE) | 30.79 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.57 |
Stock Price Statistics
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company's stock has declined approximately -5.41012% over the past 52 weeks. The 50-day moving average sits at 698.00, while the 200-day moving average is 698.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -5.41012% |
| 50-Day Moving Average | 698.00 |
| 200-Day Moving Average | 698.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company generated 131.43M in revenue and converted that into 55.93M in net income, yielding earnings per share of 3.75. EBITDA reached 41.25M, while operating income came in at 41.25M.
| Revenue | 131.43M |
| Gross Profit | 109.68M |
| Operating Income | 41.25M |
| Pretax Income | 55.93M |
| Net Income | 55.93M |
| EBITDA | 41.25M |
| EBIT | 41.25M |
| Earnings Per Share (EPS) | 3.75 |
Balance Sheet
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company holds 88.15M in cash and equivalents against 232.73M in total debt, resulting in a net debt position of -77.25M. Total book value stands at 75.15M, with working capital of 18.41M providing operational flexibility.
| Cash & Cash Equivalents | 88.15M |
| Total Debt | 232.73M |
| Net Debt | -77.25M |
| Equity (Book Value) | 75.15M |
| Book Value Per Share | 5.03 |
| Working Capital | 18.41M |
Margins
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company operates with a gross margin of 83.45, reflecting its pricing power and cost economics. The operating margin of 31.38 and net profit margin of 42.56 provide insight into operational efficiency.
| Gross Margin | 83.45 |
| Operating Margin | 31.38 |
| Pretax Margin | 42.56 |
| Profit Margin | 42.56 |
| EBITDA Margin | 31.38 |
Stock Splits
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company's most recent stock split took place on February 6, 2024 with a 1:10 split ratio.
| Last Split Date | 2/6/2024 |
| Split Ratio | 1:10 |
Scores
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company posts an Altman Z-Score of 0.32, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.32 |